Gyaviira Nkurunungi 🇺🇬👨🏾‍🔬

Immuno-epidemiology📑 | Vaccines | Parasitic infections | Helminths 🐛 | Infectious and Tropical🏝️ Diseases |

[Gyaviira Nkurunungi 🇺🇬👨🏾‍🔬 @GyavN]

The Immune Response to Infection (Chapter 15) - Principles of Medicine in Africa - https://t.co/CyJlnhLAqs

[Class 2000-05 @SmackOutkasts]

Outkasts💪🏿

[MRC/UVRI and LSHTM Uganda Research Unit @MRC_Uganda]

Need GPC data for your next project?

GPC data is accessible to bona fide researchers. We make it easy:

📍Review available datasets
📍Submit a short concept note
📍Connect with our data access committee

Get started here: https://t.co/EFnk0iPQmk

#OpenScience #AfricaDataHub #PopulationHealth #MRCUganda #LongitudinalData

[Gyaviira Nkurunungi 🇺🇬👨🏾‍🔬 @GyavN]

Low-Dose Yellow Fever Vaccine in Adults in Africa | New England Journal of Medicine https://t.co/zLg0RebGYM

[Eastern Africa Consortium for Clinical Research @EACCR2]

Special Congratulations to Professor Alison Elliott, Professor of Tropical Medicine, who has received an OBE (Officer of the Order of the British Empire) for services to Medicine and Global Health.

Based at the Medical Research Council Unit at the @UVRIug.

[UVRI @UVRIug]

Congratulations to Professor Alison Elliott, Professor of Tropical Medicine, who has received an OBE (Officer of the Order of the British Empire) for services to Medicine and Global Health.

Based at the Medical Research Council Unit at the Uganda Virus Research Institute.

[Gyaviira Nkurunungi 🇺🇬👨🏾‍🔬 @GyavN]

@AbenaPhD Thank you Abena

[EMBO @EMBO]

“I hope I will strengthen my current collaborations and find new ones through the EMBO Global Investigator Network,” says Gyaviira Nkurunungi @GyavN, new EMBO Global Investigator @MRC_Uganda. Read more about him and his research:
https://t.co/SmjfHRUOhH

[Gyaviira Nkurunungi 🇺🇬👨🏾‍🔬 @GyavN]

Excited to join the EMBO Global Investigator Network as its first African member! @AlisonEUganda @MRC_Uganda @The_VAnguard22 @EMBO https://t.co/nHwTDYrNlM

[EMBO YIP @EMBO_YIP]

@Krishanpal_K @IISERPune, @prem_s_kaushal @unescorcb, Yinghui Li @NTUsg, Wei Ma @NTUsg, @MotianiRaj1 @unescorcb, @mbhavana10 @DBT_inStem, @GyavN @MRC_Uganda @UVRIug @LSHTM,

[EMBO @EMBO]

Welcome and congratulations to the eleven group leaders from India, Singapore, Taiwan and Uganda who join the EMBO Global Investigator Network!
Read more:
https://t.co/9CYo5w2Ms0
#lifesciences

[Sabrina Kitaka @SabrinaKitaka]

The malaria vaccine is officially available on the UNEPI schedule

[Abena S. Amoah, PhD 👩🏾‍💻👩🏾‍🔬 @AbenaPhD]

Quite an epic edition of @LancetGH with interesting findings from the POPVAC trials (conducted by colleagues in Uganda) that aimed to elucidate the drivers of vaccine-specific immune responses in urban and rural settings in Uganda

@GyavN, @AlisonElliott @LZirimenya @MRC_Uganda

[Gyaviira Nkurunungi 🇺🇬👨🏾‍🔬 @GyavN]

The Effect of Malaria on Responses to Unrelated Vaccines in Animals and Humans: A Systematic Review and Meta‐Analysis - Zirimenya - 2024 - Parasite Immunology - Wiley Online Library https://t.co/oMazz4kl8O @LZirimenya @HypoVax @AlisonEUganda @MRC_Uganda

[HypoVax Global @HypoVax]

Key findings are out for the “Population differences in vaccine responses (POPVAC)” study of three linked, randomised controlled trials assessing the role, reversibility and mediators of immunomodulation by chronic infections

[Gyaviira Nkurunungi 🇺🇬👨🏾‍🔬 @GyavN]

The effect of BCG revaccination on the response to unrelated vaccines in urban Ugandan adolescents (POPVAC C): an open-label, randomised controlled trial - The Lancet Global Health https://t.co/zCrElZc13U
@MRC_Uganda @The_VAnguard22 @AlisonEUganda @HypoVax @LZirimenya

[Gyaviira Nkurunungi 🇺🇬👨🏾‍🔬 @GyavN]

Schistosome and malaria exposure and urban–rural differences in vaccine responses in Uganda - The Lancet Global Health https://t.co/5SqXZM0U2p
@MRC_Uganda @The_VAnguard22 @AlisonEUganda @HypoVax @LZirimenya

[Gyaviira Nkurunungi 🇺🇬👨🏾‍🔬 @GyavN]

The effect of intensive praziquantel administration on vaccine-specific responses among schoolchildren in Ugandan schistosomiasis-endemic islands (POPVAC A) - The Lancet Global Health https://t.co/Zes36T9o8C
@MRC_Uganda @The_VAnguard22 @AlisonEUganda @HypoVax @LZirimenya

[Gyaviira Nkurunungi 🇺🇬👨🏾‍🔬 @GyavN]

The effect of intermittent preventive treatment for malaria with dihydroartemisinin–piperaquine on vaccine-specific responses among schoolchildren in rural Uganda (POPVAC B) https://t.co/1ZNTy9Lb2G
@MRC_Uganda @The_VAnguard22 @AlisonEUganda @HypoVax @LZirimenya

[MRC/UVRI and LSHTM Uganda Research Unit @MRC_Uganda]

🚨 Job Alert: Professor – Head of Theme – Viral Pathogens

📍Entebbe, Uganda

Join us to lead groundbreaking virology research in sub Saharan Africa!

📝 Apply: https://t.co/fRXhRXMvfQ

📅 Closing Date: 05 July 2024